Valley Republic secures $20 million; Mustang Bio gets debt financing

By Devika Patel

Knoxville, Tenn., April 1 – There was moderate activity in the private placement markets on Monday, with two deals announced and one revised.

Valley Republic Bancorp, a Bakersfield, Calif.-based bank parent, reported that it has completed a $20 million private placement of 6% fixed-to-floaters due March 29, 2029.

New York’s Mustang Bio, Inc., a clinical-stage biopharmaceutical company, said it settled a $20 million debt financing with Horizon Technology Finance Corp. and Irvine, Calif.-based Endologix, Inc., a developer and manufacturer of minimally invasive treatments for aortic disorders, amended its facility agreement with Deerfield Private Design Fund IV, LP, extending the maturity date and tweaking the covenants.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.